1.
Montillo M. Ofatumumab: a second generation anti-CD20 monoclonal antibody in chronic lymphocytic leukemia. Hematol Meeting Rep [Internet]. 2009 Jun. 12 [cited 2024 Nov. 23];3(3). Available from: https://www.pagepress.org/journals/hmr/article/view/583